Top Banner
Outline • Epidemiology • Presentation • Investigations • Optimal management
28

Outline Epidemiology Presentation Investigations Optimal management.

Dec 22, 2015

Download

Documents

Jane Randall
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Outline Epidemiology Presentation Investigations Optimal management.

Outline

• Epidemiology

• Presentation

• Investigations

• Optimal management

Page 2: Outline Epidemiology Presentation Investigations Optimal management.

Tuberculosis notifications by site of disease (pulmonary/non-pulmonary), England and Wales, 1982-

2009

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 3: Outline Epidemiology Presentation Investigations Optimal management.

TB - Epidemiology

• Rising prevalence nationally and locally

• Traditionally mostly pulmonary TB– 60%– 40% extra-pulmonary TB

• Increasing proportion of EPTB (50%)

• 10% of EPTB are joint TB

Page 4: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - presentation

• Presentation is often insidious and atypical

• Can be sub-acute and therefore there can be a delay in diagnosis

• Painful joints may precede systemic symptoms by several weeks

• Sometimes is the tip of the iceberg of a multi-focal TB

Page 5: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - presentation

• Early– Usually a single joint– Painful– No swelling or deformity

• Later joints may become warm and swollen• Sometimes they have a fever• Look for other symptoms eg cough

Page 6: Outline Epidemiology Presentation Investigations Optimal management.

Coventry TB rate by year 1999-2006

Rate per 100,000 population

0

5

10

15

20

25

30

35

1999 2000 2001 2002 2003 2004 2005 2006

rate

Coventry PCT

West Midlands

England & Wales

Linear (Coventry PCT)

Coventry 2007

Courtesy Dr Gee

Page 7: Outline Epidemiology Presentation Investigations Optimal management.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Figure 4. Tuberculosis case reports and rates by age group and place of birth, UK, 2008

Page 8: Outline Epidemiology Presentation Investigations Optimal management.

Tuberculosis case reports and rates by place of birth and ethnic group, UK, 2008

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 9: Outline Epidemiology Presentation Investigations Optimal management.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

World health organisation

Page 10: Outline Epidemiology Presentation Investigations Optimal management.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Three-year average tuberculosis case rates by primary care organisation, UK, 2006-2008

Page 11: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB -presentation

• Ask about previous TB/contact history– But absence does not rule out TB or make it

unlikely

• Ethnicity is important• Think osteo-articular TB …• Have a high index of suspicion..

– In a young patient with a single chronic painful joint and from an area of high background incidence of TB

Page 12: Outline Epidemiology Presentation Investigations Optimal management.

TB

• Beware of the young patient (from an area of high incidence) with backache that doesn’t go away

• Must also consider the diagnosis in pregnant ladies

Page 13: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - Investigations

• Plain x-rays often normal• MRI can be helpful in diagnosis1

– But there needs to be a high index of suspicion to request this

• Aspiration of synovial fluid for TB culture • Synovial biopsy

– ie tissue for TB culture should sent in saline or water

– Higher yield2

1. Desai.J Bone Joint surg Br.19942. osteoarticular TB in a general hospital in the last decade.ruiz.clin microbiol

infect.2003

Page 14: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - Management

• Standard quadruple therapy*• Rifampicin• Isoniazid• Pyrazinamide• Ethambutol

*short course chemotherapy for spinal Tb.parthasarathy.journal of bone and joint surgery.1999

Page 15: Outline Epidemiology Presentation Investigations Optimal management.

How long for?

Page 16: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - management

• Usually 6 months is standard

• No controlled trials for peripheral joint TB

• 6 months?

• 12 months?

• Do they require surgery?

Page 17: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - management

• 1A multicentre MRC study of spinal tuberculosis suggests good results can be achieved with 6-9 months of treatment and this is currently the recommendation of The British Thoracic Society Guidelines/NICE

1.Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Int Orthop. 1999; 23(2): 73-81

Page 18: Outline Epidemiology Presentation Investigations Optimal management.

Outcome at 5 yearsOutcome Hong Kong

Surgery+6HRsNo %

Hong KongSurgery+9HRsNo %

MadrasSurgery+6HRNo %

Madras6HRNo %

Madras9HRNo %

Favourable 23 96 25 96 72 88 75 91 84 98

Unfavourable 1 4

1 4 10 9 7 8 2 2

Total 24 26 82 82 86

Page 19: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - management

• Even quite extensive joint disease with severe radiographic changes can resolve with medical treatment alone

Page 20: Outline Epidemiology Presentation Investigations Optimal management.

Joint TB - management

• However, if treatment is delayed, there can be considerable loss of function and a requirement for extensive surgical intervention.

Page 21: Outline Epidemiology Presentation Investigations Optimal management.

Key messages

• Peripheral joint tuberculosis should be considered in any patient with chronic joint pain

• and particularly if there is swelling present • and especially if the patient is from an ethnic

group with a high background incidence of tuberculosis.

• Biopsy and culture is important to identify MDR-TB

• Chemotherapy is sufficient in many cases and surgery is helpful in selected cases

Page 22: Outline Epidemiology Presentation Investigations Optimal management.

Supplementary slides

Page 23: Outline Epidemiology Presentation Investigations Optimal management.

Short course chemotherapy

• MRC working party on TB of spine

• 3 countries: Hong Kong, India and Korea

• 3 randomised trials

• 5 year assessment

International Orthopaedics 1999 23 : 73-81

Page 24: Outline Epidemiology Presentation Investigations Optimal management.

International Orthopaedics 1999 23 : 73-81

Short course chemotherapy

• Comparison of ….– Hong Kong radical resection +6HRS– Ambulant therapy 6HR (medical)– Ambulant therapy 9HR (medical)

Page 25: Outline Epidemiology Presentation Investigations Optimal management.

International Orthopaedics 1999 23 : 73-81

Short course chemotherapy

• Outcomes– Unfavourable outcome– Favourable outcome

• (full functional activity, radiologically quiescent, no myelopathy with functional impairment, modification of therapy)

Page 26: Outline Epidemiology Presentation Investigations Optimal management.

Therapy

• Medical therapy usually sufficient

• Surgery in selected cases (cord compression, progressive neurology, marked kyphosis)

• 6(-9) months therapy – 2HRZE+ 4HR

Page 27: Outline Epidemiology Presentation Investigations Optimal management.

Indications for surgery

• patients aged less than 15 years, in whom the initial angle of kyphosis is more than 30º

• patients started on ambulant chemotherapy who develop progressive kyphosis

Page 28: Outline Epidemiology Presentation Investigations Optimal management.

Indications for surgery

• children aged less than ten years with destruction of vertebral bodies who have partial or no fusion even during programme

• patients with compression of the spinal cord in whom the neurological status deteriorates in spite of chemotherapy